J. Goldman & CO LP Sutro Biopharma, Inc. Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $330,984 - $546,531	-23,227 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $813,835 - $1.08 Million	-48,213 Reduced 67.49%	23,227 $439,000
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $406,107 - $536,521	22,524 Added 46.05%	71,440 $1.33 Million
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $1.94 Million - $2.64 Million	-95,700 Reduced 66.18%	48,916 $1.11 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $1.47 Million - $3.47 Million	144,616 New	144,616 $3.14 Million

128

59.9M

203K

33.6K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $89.2M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.